KZ · BINActiveBIN 250340016949
No risks found

ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "GENEMIND"

Director
Калюжный Александр Александрович
Incorporated
17.03.2025
Address
Астана ул. СЫҒАНАҚ, 54, Н.П. 17
Risk by category
Listed in the register of declared bankrupts0/1
Legal entity declared a sham company0/1
Listed in the register of dormant taxpayers0/1
Not present at its registered address0/1
Tax arrears over 150 MCI (sole traders — 10 MCI)0/1
Bad-faith public-procurement participant0/1
Bad-faith supplier to Samruk-Kazyna0/1
Bad-faith supplier to NIS0/1
Restricted from issuing electronic invoices0/1
Arrears on social health-insurance contributions0/1
Listed as a company whose registration was invalidated0/1
Listed as a company whose re-registration was invalidated0/1
Liquidated according to the tax authority0/1
High risk category in the tax risk-management system0/1
Arrears on mandatory pension contributions0/1
Arrears on social contributions0/1
Arrears on customs duties and payments0/1

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

01Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "GENEMIND"
BIN
250340016949
Status
Active
Director
Калюжный Александр Александрович
Registration date
17.03.2025
Activity
Производство лекарственных препаратов для ветеринарии
Legal address
Астана ул. СЫҒАНАҚ, 54, Н.П. 17
VAT payer
No
КАТО
711210000
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.

Activities

1
21202primary

Производство лекарственных препаратов для ветеринарии

Contacts

Change history

02Financials

Financial statements

Premium

Public contracts

Assets

Bank accounts

03People & owners

Leadership

1
  • КА

    Калюжный Александр Александрович

    Director

    since 17.03.2025

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

04Risk & checks

Risks

0/17
Tax risk (КГД risk category)Medium
Listed in the register of declared bankruptsOK
Legal entity declared a sham companyOK
Listed in the register of dormant taxpayersOK
Not present at its registered addressOK
Tax arrears over 150 MCI (sole traders — 10 MCI)OK
Bad-faith public-procurement participantOK
Bad-faith supplier to Samruk-KazynaOK
Bad-faith supplier to NISOK
Restricted from issuing electronic invoicesOK
Arrears on social health-insurance contributionsOK
Listed as a company whose registration was invalidatedOK
Listed as a company whose re-registration was invalidatedOK
Liquidated according to the tax authorityOK
High risk category in the tax risk-management systemOK
Arrears on mandatory pension contributionsOK
Arrears on social contributionsOK
Arrears on customs duties and paymentsOK

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

05Networks & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "GENEMIND" (BIN 250340016949) is an active legal entity in Астана, registered in 2025 (1 year on the market). Primary activity — производство лекарственных препаратов для ветеринарии. Automated screening of open registries found no risk indicators for "GENEMIND". Director on record — Калюжный Александр Александрович. Data current as of August 30, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.